Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Recruiting now · Not applicable
Conditions studied: Breast Neoplasms, Breast Cancer
In brief
The goal of this randomized controlled pilot study is to assess the feasibility, acceptability, and preliminary effects of the PACHA program designed for women having an adjuvant endocrine therapy (AET) after hormone-sensitive breast cancer. PACHA (programme en Pharmacie pour l'ACcompagnement des femmes ayant de l'Hormonothérapie Adjuvante) is a community pharmacy-based program aimed at optimizing the experience of AET and its use. The main questions it aims to answer are : * Does the program have an effect on factors expected to influence AET adherence? * Is the program acceptable? * Is the implementation of the program feasible? * What is the feasibility of procedures for carrying out a full-scale study? Participating community pharmacies will be randomized. Pharmacists working in pharmacies assigned to the PACHA group (33 pharmacies) will receive web-based training and manuals to use during their consultations with women having an AET. Recruited women attending these pharmacies will also have access to information and resources about AET (videos, evidence-based booklet). Pharmacists practicing in pharmacies assigned to the control group (33 pharmacies) will provide usual care.
Key facts
- Study ID
- NCT05887102
- Run by
- CHU de Quebec-Universite Laval
- People needed
- 66
- Starts
- 2023-06-07
- Expected to finish
- 2025-03-01
- Last updated by the study team
- 2024-08-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- For pharmacies :
- In the province of Quebec, Canada
- At least one pharmacist agrees to take charge of the project in their pharmacy
- At least one women has initiated adjuvant endocrine therapy (AET) in the last 6 months in the pharmacy
- For pharmacists :
- Practicing in a pharmacy in the province of Quebec
- Provide consent
- For women :
- 18 years old or older
- Were diagnosed with a first non-metastatic, hormone-sensitive breast cancer
- Received and AET prescription for the first time in the last 6 months
- Are fluent in French
- Have internet access
- Provide consent
You may not qualify if…
- For women :
- Live in a residential facility where AET is not self-managed
Where it is running
- Centre de recherche du CHU de Québec — Québec, Quebec, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.